Cargando…
Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities
The treatment of advanced renal cell carcinoma (RCC) remains a major therapeutic challenge for clinicians. Despite advances in the understanding of the immunobiology of RCC and the availability of several novel targeted agents, there has been little improvement in the survival of patients with metas...
Autores principales: | Graves, Angela, Hessamodini, Hannah, Wong, Germaine, Lim, Wai H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928369/ https://www.ncbi.nlm.nih.gov/pubmed/27471690 http://dx.doi.org/10.2147/ITT.S31426 |
Ejemplares similares
-
Targeted Therapy for Metastatic Renal Carcinoma: an Update
por: da Silva, Rodrigo Donalisio, et al.
Publicado: (2014) -
Update on the treatment of metastatic renal cell carcinoma
por: Medina López, Rafael Antonio, et al.
Publicado: (2022) -
Impact of treatment modalities on prognosis of patients with metastatic renal collecting duct carcinoma
por: Qian, Xiaoyuan, et al.
Publicado: (2022) -
Therapeutic Sequencing in Metastatic Renal Cell Carcinoma
por: Maia, Manuel Caitano, et al.
Publicado: (2017) -
Updates in the Management of Renal Cell Carcinoma
por: Hanna, Kirollos S., et al.
Publicado: (2022)